All News

Found 2,353 articles

• Agenovir Appoints Industry Veteran Dirk Thye, M.D. As CEO

  12/8/2016

• Roaring Intellia Moves Into New HQ, Allowing Company to Double Staff and Advance CRISPR/Cas9 Pipeline

  12/5/2016

• Evotec AG And Merck & Co. Enter Into Agreements To Collaborate On Target Discovery Technologies

  11/30/2016

• Cellecta, Inc. Launches Driver-Map Human Genome-Wide Expression Profiling Service For 19,000 Human Genes

  11/29/2016

• Dr. David Tuveson Named Director, NCI-Designated Cancer Center At Cold Spring Harbor Laboratory

  11/29/2016

• Vasuda Global Orphan/Rare Disease Index Announces The Quarterly Recomposition And Rebalancing

  11/23/2016

• China Takes Lead in CRISPR Race, Will Test on a Human for the First Time

  11/16/2016

• Recombinetics Closes $10 Million Stock Offering

  11/14/2016

• Evotec AG Reports Results Of First Nine Months Of 2016

  11/10/2016

• Stanford University Researchers Use CRISPR to Repair Gene That Cause Sickle Cell, Human Trials Planned

  11/8/2016

• ERS Genomics And Knudra Transgenics Sign License Agreement On CRISPR-Cas9 Genome Editing Patents For Model-Organisms

  11/2/2016

• Serial Biotech Startup Creator Third Rock Ventures Nabs a Record $616 Million

  11/1/2016

• Former Sanofi Genzyme Exec to Helm CRISPR/Cas9 Developer Casebia Therapeutics

  11/1/2016

• ERS Genomics And Evolva Sign License Agreement On CRISPR-Cas9 Genome Editing Patents For Industrial Applications

  10/27/2016

• 4 Biotech Stocks on the Brink of a Major Breakthrough

  10/25/2016

• The Jackson Laboratory And Caribou Biosciences Announce CRISPR-Cas9 License Agreement

  10/25/2016

• CRISPR's Surprisingly Low IPO… Why Are Investors Discouraged?

  10/21/2016

• Biotech Goes Hollywood Again as Jennifer Lopez Set to Produce New Show About CRISPR Gene-Editing

  10/20/2016

• CRISPR IPO Brings Home $56 Million, Half of What Its Rival Took in Earlier This Year

  10/20/2016

• 19 Bay Area Biotechs to Watch at BIO's Investor Forum This Week

  10/19/2016